X

Trial Profile

Pharmacokinetics of Anidulafungin (Ecalta) Given Intravenously as Prophylaxis to Obese Patients With Risk of Invasive Fungal Infection Undergoing Gastric Bypass Surgery

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Feb 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anidulafungin (Primary)
Indications Mycoses
Focus Pharmacokinetics
Acronyms ADOPT

Most Recent Events

03 May 2016 Results published in the Clinical Pharmacokinetics
27 Oct 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
20 Jun 2014 Planned End Date changed from 1 Dec 2014 to 1 Mar 2015.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com